Teligent Financials

Teligent Stock Summary

Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. On October 14, 2021, Teligent, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Teligent operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 142 people.

Teligent Key Financial Ratios

Teligent Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Teligent's current stock value. Our valuation model uses many indicators to compare Teligent value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teligent competition to find correlations between indicators driving Teligent's intrinsic value. More Info.Teligent is rated third in return on asset category among its peers. It is currently regarded as top stock in profit margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Teligent by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

If you are still planning to invest in Teligent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Teligent's history and understand the potential risks before investing.